Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-methyl-5-nitro-2-(4-(trifluoromethyl)phenyl)pyridine is a complex organic chemical compound characterized by a pyridine ring structure. It features a methyl group at the 3rd position, a nitro group at the 5th position, and a 4-(trifluoromethyl)phenyl group attached at the 2nd position. 3-methyl-5-nitro-2-(4-(trifluoromethyl)phenyl)pyridine is notable for its potential applications in the synthesis of pharmaceuticals and agrochemicals, given its structural diversity and the presence of electron-withdrawing groups that can influence its reactivity and biological activity. The trifluoromethyl group, in particular, can significantly alter the lipophilicity and metabolic stability of the molecule, which are important considerations in drug design.

872254-88-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 872254-88-1 Structure
  • Basic information

    1. Product Name: 3-methyl-5-nitro-2-(4-(trifluoromethyl)phenyl)pyridine
    2. Synonyms: 3-methyl-5-nitro-2-(4-(trifluoromethyl)phenyl)pyridine
    3. CAS NO:872254-88-1
    4. Molecular Formula: C13H9F3N2O2
    5. Molecular Weight: 282.222
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 872254-88-1.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 3-methyl-5-nitro-2-(4-(trifluoromethyl)phenyl)pyridine(CAS DataBase Reference)
    10. NIST Chemistry Reference: 3-methyl-5-nitro-2-(4-(trifluoromethyl)phenyl)pyridine(872254-88-1)
    11. EPA Substance Registry System: 3-methyl-5-nitro-2-(4-(trifluoromethyl)phenyl)pyridine(872254-88-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 872254-88-1(Hazardous Substances Data)

872254-88-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 872254-88-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,2,2,5 and 4 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 872254-88:
(8*8)+(7*7)+(6*2)+(5*2)+(4*5)+(3*4)+(2*8)+(1*8)=191
191 % 10 = 1
So 872254-88-1 is a valid CAS Registry Number.

872254-88-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-methyl-5-nitro-2-(4-(trifluoromethyl)phenyl)pyridine

1.2 Other means of identification

Product number -
Other names 3-methyl-5-nitro-2-(4-trifluoromethyl-phenyl)-pyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:872254-88-1 SDS

872254-88-1Relevant articles and documents

Glucagon Receptor Modulators

-

Page/Page column 43, (2012/07/13)

The present invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof wherein R1, R2, R3, A1, A2, A3, A4, L, B1, B2, B3 and B4 are as defined herein. The compounds of Formula I have been found to act as glucagon antagonists or inverse agonists. Consequently, the compounds of Formula I and the pharmaceutical compositions thereof are useful for the treatment of diseases, disorders, or conditions mediated by glucagon.

GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES

-

Page/Page column 50-51, (2010/02/15)

The present invention discloses novel compounds of Formula I, or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 872254-88-1